NCT01497483View on ClinicalTrials.gov

Drug-Drug Interaction Study With Pravastatin and Cyclosporine

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

December 31, 2013

Conditions
Healthy
Interventions
DRUG

Pravastatin alone

Pravastatin 40 mg with placebo.

DRUG

Pravastatin and Cyclosporine

Pravastatin 40 mg co-administered with 200 mg of cyclosporine.

Trial Locations (1)

94110

San Francisco General Hosptail, San Francisco

All Listed Sponsors
collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

University of California, San Francisco

OTHER

NCT01497483 - Drug-Drug Interaction Study With Pravastatin and Cyclosporine | Biotech Hunter | Biotech Hunter